Follow on Google News News By Tag * Tissue Engineering * Pancreatic Beta-cell Clusters * John Jansen * Cell Clusters * Insulin * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Method Yields Insulin-Producing Pancreatic Cell ClustersThree-dimensional clusters of pancreatic beta-cells that live much longer and secrete more insulin than single cells grown in the laboratory are valuable new tools for studying pancreatic diseases such as diabetes and for testing novel therapies.
New Method Yields Insulin-Producing Pancreatic Cell Clusters New Rochelle, NY—Three-dimensional clusters of pancreatic beta-cells that live much longer and secrete more insulin than single cells grown in the laboratory are valuable new tools for studying pancreatic diseases such as diabetes and for testing novel therapies. This cutting-edge advance is described in an article in Tissue Engineering, Part C, Methods, a peer-reviewed journal from Mary Ann Liebert, Inc. (http://www.liebertpub.com) “Finding a solution for the culturing and final transplantation of pancreatic cells will be an enormous breakthrough for the treatment of diabetes," says John Jansen, DDS, PhD, Methods Co-Editor-in- Growing pancreatic cells in the laboratory is challenging, in part because to survive and function normally they require cell-cell contact. Abigail Bernard, Chien-Chi Lin, PhD, and Kristi Anseth, PhD, University of Colorado at Boulder, and Indiana University-Purdue University at Indianapolis, developed an innovative method that uses photolithography to create microwell cell culture environments that support the formation of 3-D pancreatic beta-cell clusters and control the size of the cell aggregates. They describe the ability to remove these cell clusters from the microwells and encapsulate them in hydrogels for subsequent testing or implantation. They present their work in the article “A Microwell Cell Culture Platform for the Aggregation of Pancreatic Beta-Cells.” About the Journal Tissue Engineering is an authoritative peer-reviewed journal published monthly in print and online in three parts: Part A--the flagship journal; Part B—Reviews; # # # About the Company Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Stem Cells and Development, Human Gene Therapy and HGT Methods, and Biopreservation and Biobanking. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available at Mary Ann Liebert Inc. (http://www.liebertpub.com) End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|